Healthcare of Ontario Pension Plan Trust Fund Takes Position in Encompass Health Co. (NYSE:EHC)

Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Encompass Health Co. (NYSE:EHC) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,428 shares of the company’s stock, valued at approximately $201,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Principal Securities Inc. acquired a new position in shares of Encompass Health during the fourth quarter valued at about $25,000. Benjamin F. Edwards & Company Inc. raised its position in shares of Encompass Health by 360.2% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock valued at $27,000 after purchasing an additional 317 shares during the period. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Encompass Health in the fourth quarter valued at approximately $30,000. GAMMA Investing LLC bought a new stake in shares of Encompass Health in the fourth quarter valued at approximately $33,000. Finally, Parallel Advisors LLC increased its holdings in Encompass Health by 192.3% during the 4th quarter. Parallel Advisors LLC now owns 573 shares of the company’s stock worth $38,000 after acquiring an additional 377 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the topic of a number of analyst reports. Royal Bank of Canada upped their target price on shares of Encompass Health from $83.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, May 22nd. Truist Financial boosted their price target on shares of Encompass Health from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, July 15th. Mizuho boosted their price target on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Stephens reaffirmed an “overweight” rating and issued a $94.00 price objective on shares of Encompass Health in a research note on Wednesday, June 5th. Finally, Barclays upped their price objective on shares of Encompass Health from $108.00 to $113.00 and gave the company an “overweight” rating in a research note on Wednesday, July 10th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $96.50.

Encompass Health Stock Up 1.1 %

Shares of Encompass Health stock opened at $91.64 on Friday. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.37. The company has a 50-day moving average of $85.59 and a 200 day moving average of $80.14. The firm has a market cap of $9.23 billion, a price-to-earnings ratio of 24.77, a PEG ratio of 1.42 and a beta of 0.89. Encompass Health Co. has a 1 year low of $57.55 and a 1 year high of $91.96.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. The business had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. Encompass Health’s revenue was up 13.4% compared to the same quarter last year. During the same period last year, the business earned $0.88 EPS. As a group, sell-side analysts anticipate that Encompass Health Co. will post 4.09 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date of this dividend is Tuesday, October 1st. This is an increase from Encompass Health’s previous quarterly dividend of $0.15. Encompass Health’s dividend payout ratio (DPR) is presently 16.22%.

Insider Activity

In related news, insider Elissa Joy Charbonneau sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $85.02, for a total value of $850,200.00. Following the transaction, the insider now owns 18,594 shares of the company’s stock, valued at $1,580,861.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Encompass Health news, CEO Mark J. Tarr sold 44,976 shares of the firm’s stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $83.27, for a total transaction of $3,745,151.52. Following the sale, the chief executive officer now owns 554,098 shares in the company, valued at approximately $46,139,740.46. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Elissa Joy Charbonneau sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $85.02, for a total transaction of $850,200.00. Following the sale, the insider now owns 18,594 shares in the company, valued at approximately $1,580,861.88. The disclosure for this sale can be found here. Insiders have sold a total of 69,519 shares of company stock valued at $5,816,091 in the last 90 days. 2.10% of the stock is currently owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.